Ignite Creation Date:
2025-12-25 @ 1:28 AM
Ignite Modification Date:
2026-03-22 @ 4:11 PM
Study NCT ID:
NCT00324194
Status:
COMPLETED
Last Update Posted:
2015-01-08
First Post:
2006-05-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Study of MGCD0103 Given Twice Weekly in Patients With Leukemia or Myelodysplastic Syndromes
Sponsor:
Mirati Therapeutics Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
0103-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Gregory Reid, Chief Medical Officer
Old Organization:
MethylGene, Inc.